Standard
Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma. / Mai, Elias K; Hielscher, Thomas; Bertsch, Uta; Schlenzka, Jana; Salwender, Hans J; Munder, Markus; Gerecke, Christian; Dührsen, Ulrich; Brossart, Peter; Neben, Kai; Hillengass, Jens; Raab, Marc S; Merz, Maximilian; Baertsch, Marc-Andrea; Jauch, Anna; Hose, Dirk; Martin, Hans; Lindemann, Hans-Walter; Blau, Igor W; Scheid, Christof; Weisel, Katja C; Goldschmidt, Hartmut; German-speaking Myeloma Multicenter Group (GMMG).
in:
LEUKEMIA, Jahrgang 33, Nr. 1, 01.2019, S. 258-261.
Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
Mai, EK, Hielscher, T, Bertsch, U, Schlenzka, J, Salwender, HJ, Munder, M, Gerecke, C, Dührsen, U, Brossart, P, Neben, K, Hillengass, J, Raab, MS, Merz, M, Baertsch, M-A, Jauch, A, Hose, D, Martin, H, Lindemann, H-W, Blau, IW, Scheid, C
, Weisel, KC, Goldschmidt, H & German-speaking Myeloma Multicenter Group (GMMG) 2019, '
Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma',
LEUKEMIA, Jg. 33, Nr. 1, S. 258-261.
https://doi.org/10.1038/s41375-018-0195-9APA
Mai, E. K., Hielscher, T., Bertsch, U., Schlenzka, J., Salwender, H. J., Munder, M., Gerecke, C., Dührsen, U., Brossart, P., Neben, K., Hillengass, J., Raab, M. S., Merz, M., Baertsch, M-A., Jauch, A., Hose, D., Martin, H., Lindemann, H-W., Blau, I. W., ... German-speaking Myeloma Multicenter Group (GMMG) (2019).
Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma.
LEUKEMIA,
33(1), 258-261.
https://doi.org/10.1038/s41375-018-0195-9Vancouver
Bibtex
@article{91288c1955cd49a5a41cb24c1734d1cc,
title = "Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma",
keywords = "Journal Article",
author = "Mai, {Elias K} and Thomas Hielscher and Uta Bertsch and Jana Schlenzka and Salwender, {Hans J} and Markus Munder and Christian Gerecke and Ulrich D{\"u}hrsen and Peter Brossart and Kai Neben and Jens Hillengass and Raab, {Marc S} and Maximilian Merz and Marc-Andrea Baertsch and Anna Jauch and Dirk Hose and Hans Martin and Hans-Walter Lindemann and Blau, {Igor W} and Christof Scheid and Weisel, {Katja C} and Hartmut Goldschmidt and {German-speaking Myeloma Multicenter Group (GMMG)}",
year = "2019",
month = jan,
doi = "10.1038/s41375-018-0195-9",
language = "English",
volume = "33",
pages = "258--261",
journal = "LEUKEMIA",
issn = "0887-6924",
publisher = "NATURE PUBLISHING GROUP",
number = "1",
}
RIS
TY - JOUR
T1 - Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma
AU - Mai, Elias K
AU - Hielscher, Thomas
AU - Bertsch, Uta
AU - Schlenzka, Jana
AU - Salwender, Hans J
AU - Munder, Markus
AU - Gerecke, Christian
AU - Dührsen, Ulrich
AU - Brossart, Peter
AU - Neben, Kai
AU - Hillengass, Jens
AU - Raab, Marc S
AU - Merz, Maximilian
AU - Baertsch, Marc-Andrea
AU - Jauch, Anna
AU - Hose, Dirk
AU - Martin, Hans
AU - Lindemann, Hans-Walter
AU - Blau, Igor W
AU - Scheid, Christof
AU - Weisel, Katja C
AU - Goldschmidt, Hartmut
AU - German-speaking Myeloma Multicenter Group (GMMG)
PY - 2019/1
Y1 - 2019/1
KW - Journal Article
U2 - 10.1038/s41375-018-0195-9
DO - 10.1038/s41375-018-0195-9
M3 - SCORING: Journal article
C2 - 29959413
VL - 33
SP - 258
EP - 261
JO - LEUKEMIA
JF - LEUKEMIA
SN - 0887-6924
IS - 1
ER -
